Gene · 593
Papers1,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aptamer-Functionalized Hybrid Nanostructures for Sensing, Drug Delivery, Catalysis and Mechanical Applications. | Int J Mol Sci | 2021 | 33670386 | PubTator, text mining | PubMed |
| Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts. | Int J Mol Sci | 2021 | 33669532 | PubTator, text mining | PubMed |
| Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells. | Cancers (Basel) | 2021 | 33668151 | PubTator, text mining | PubMed |
| Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic KRAS mutant colon cancer. | Theranostics | 2021 | 33664850 | PubTator, text mining | PubMed |
| Clinical exome sequencing reveals a mutation in PDHA1 in Leigh syndrome: A case of a Chinese boy with lethal neuropathy. | Mol Genet Genomic Med | 2021 | 33661577 | PubTator, text mining | PubMed |
| The Strategy of Conditionally Replicating Adenovirus-Mediated PreS2 Mini-Antibody Expression Has Dual Effects of Inhibiting HBV Infection and Preventing Hepatocellular Carcinoma. | Cancer Manag Res | 2021 | 33658851 | PubTator, text mining | PubMed |
| Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma. | Bioengineered | 2021 | 33641617 | PubTator, text mining | PubMed |
| Whole-body metabolic fate of branched-chain amino acids. | Biochem J | 2021 | 33626142 | PubTator, text mining | PubMed |
| Identification of the first Alu-mediated gross deletion involving the BCKDHA gene in a compound heterozygous patient with maple syrup urine disease. | Clin Chim Acta | 2021 | 33607070 | PubTator, text mining | PubMed |
| A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery. | Commun Biol | 2021 | 33594247 | PubTator, text mining | PubMed |
| Novel presentations associated with a PDHA1 variant - Alternating hemiplegia in Hemizygote proband and Guillain Barre Syndrome in Heterozygote mother. | Eur J Paediatr Neurol | 2021 | 33592356 | PubTator, text mining | PubMed |
| Structural and functional impact of clinically relevant E1α variants causing pyruvate dehydrogenase complex deficiency. | Biochimie | 2021 | 33588022 | PubTator, text mining | PubMed |
| Glycine Cleavage System H Protein Is Essential for Embryonic Viability, Implying Additional Function Beyond the Glycine Cleavage System. | Front Genet | 2021 | 33569080 | PubTator, text mining | PubMed |
| USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | J Biol Chem | 2021 | 33567341 | PubTator, text mining | PubMed |
| Novel urinary glycan profiling by lectin array serves as the biomarkers for predicting renal prognosis in patients with IgA nephropathy. | Sci Rep | 2021 | 33564009 | PubTator, text mining | PubMed |
| Viral vector platforms within the gene therapy landscape. | Signal Transduct Target Ther | 2021 | 33558455 | PubTator, text mining | PubMed |
| Mesenchymal stem cells and oncolytic viruses: joining forces against cancer. | J Immunother Cancer | 2021 | 33558278 | PubTator, text mining | PubMed |
| Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease. | Stem Cells Transl Med | 2021 | 33547875 | PubTator, text mining | PubMed |
| Unique Metabolomic Profile of Skeletal Muscle in Chronic Limb Threatening Ischemia. | J Clin Med | 2021 | 33540726 | PubTator, text mining | PubMed |
| Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models. | Invest New Drugs | 2021 | 33534026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/593/papers?page=20